Neuromeka Co., Ltd.
348340.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
19
Cost of Revenue
16
Gross Profit
3
Gross Margin
16.4%
Operating Income
-14
Operating Margin
-75.2%
Net Income
-13
Net Margin
-66.3%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-7
EBITDA Margin
-37.5%
2023
12/31/2023
Revenue
10
Cost of Revenue
9
Gross Profit
1
Gross Margin
8.9%
Operating Income
-11
Operating Margin
-107.9%
Net Income
-13
Net Margin
-128.5%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-11
EBITDA Margin
-106.2%
2022
12/31/2022
Revenue
7
Cost of Revenue
6
Gross Profit
1
Gross Margin
11.8%
Operating Income
-6
Operating Margin
-79.9%
Net Income
-6
Net Margin
-84.1%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-5
EBITDA Margin
-70.8%
2021
12/31/2021
Revenue
6
Cost of Revenue
4
Gross Profit
1
Gross Margin
25.0%
Operating Income
-2
Operating Margin
-40.9%
Net Income
-5
Net Margin
-89.7%
EPS (Basic)
$-3.00
EPS (Diluted)
$-3.00
EBITDA
-4
EBITDA Margin
-70.4%
2020
12/31/2020
Revenue
3
Cost of Revenue
3
Gross Profit
0
Gross Margin
6.1%
Operating Income
-6
Operating Margin
-200.6%
Net Income
-6
Net Margin
-203.4%
EPS (Basic)
$-5.00
EPS (Diluted)
$-5.00
EBITDA
-5
EBITDA Margin
-167.6%